Calcium Channel CaV1 Splice Isoforms - Tissue Specificity and Drug Action

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|8|1|22-31

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.8, Iss.1, 2015-01, pp. : 22-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphenol A differently inhibits CaV3.1, CaV3.2 and CaV3.3 calcium channels

By Michaela Pavlovičová   Mária Karmažínová   Silvia Huláková   Ľubica Lacinová  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 387, Iss. 2, 2014-02 ,pp. : 153-163

Springer Publishing Company

Access to resources Recommend Favorite

Molecular determinants of Ca 2+ channel function and drug action

By Varadi G.   Mori Y.   Mikala G.   Schwartz A.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 2, 1995-02 ,pp. : 43-49

Elsevier

Access to resources Recommend Favorite

Regulation of Postsynaptic Stability by the L-type Calcium Channel CaV1.3 and its Interaction with PDZ Proteins

By  

Current Molecular Pharmacology, Vol. 8, Iss. 1, 2015-01 ,pp. : 95-101

Bentham Science Publishers

Access to resources Recommend Favorite

The rat mGlu 1d receptor splice variant shares functional properties with the other short isoforms of mGlu 1 receptor

By Mary S.   Stephan D.   Gomeza J.   Bockaert J.   Pruss R.M.   Pin J.-P.  

European Journal of Pharmacology, Vol. 335, Iss. 1, 1997-09 ,pp. : 65-72

Elsevier

Access to resources Recommend Favorite

Myocardial Action Potential Prolongation by Calcium Channel Activation Under Calcium Free-EGTA Condition in Rats: Developmental and Regional Variations

By Tanaka H.   Noguchi K.   Shigenobu K.  

General Pharmacology, Vol. 26, Iss. 1, 1995-01 ,pp. : 39-43

Elsevier

Access to resources Recommend Favorite